Want to see KR:145720 full AI Analyst Report?
Dentium Co., Ltd. (145720) AI Stock Analysis
Dentium Co., Ltd.
(Korea Exchange:145720)
The score is held back mainly by weakening earnings quality and negative recent free cash flow, despite still-healthy operating margins and a manageable balance sheet. Technical indicators are largely neutral and do not add strong conviction. Offsetting these risks, the stock screens as attractively valued with a low P/E and a modest dividend yield.
Dentium Co., Ltd. (145720) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- KRW 333.49B
- Dividend Yield
- 1.49%
- Average Volume (3M)
- 22.81K
- Price to Earnings (P/E)
- 11.3
- Beta (1Y)
- 0.11
- Revenue Growth
- -6.55%
- EPS Growth
- -58.05%
- Country
- KR
- Employees
- 876
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Instruments & Supplies
Dentium Co., Ltd. Business Overview & Revenue Model
Company Description
Dentium Co., Ltd., based in Seoul, South Korea, is a prominent global manufacturer and supplier of cutting-edge dental implant solutions. The company's extensive product range encompasses various dental implant systems, such as Superline, Implantium,...
Dentium Co., Ltd. Financial Statement Overview
Summary
Profitability remains solid with strong TTM gross and operating margins (gross ~61.8%, EBIT ~19.9%), and leverage is moderate (debt-to-equity ~0.50). However, earnings quality has weakened materially: net margin fell to ~8.8% TTM from ~17.8% in 2024 and ROE dropped to ~5.3% TTM. The biggest concern is cash conversion—free cash flow is negative in TTM (about -20.7B) and was also negative in 2025, reducing near-term financial flexibility.
Income Statement
68PositiveBalance Sheet
72PositiveCash Flow
34Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 348.09B | 346.45B | 407.81B | 393.19B | 355.87B | 291.53B |
| Gross Profit | 215.08B | 205.82B | 260.25B | 278.84B | 260.68B | 193.15B |
| EBITDA | 96.21B | 87.39B | 126.72B | 162.80B | 144.14B | 94.00B |
| Net Income | 30.49B | 16.80B | 72.71B | 96.52B | 86.07B | 55.48B |
Balance Sheet | ||||||
| Total Assets | 986.84B | 933.07B | 894.43B | 773.77B | 674.58B | 570.20B |
| Cash, Cash Equivalents and Short-Term Investments | 75.93B | 88.51B | 109.83B | 86.91B | 72.05B | 65.84B |
| Total Debt | 300.44B | 288.04B | 256.73B | 208.76B | 208.56B | 192.97B |
| Total Liabilities | 392.20B | 371.46B | 340.92B | 309.90B | 301.42B | 279.10B |
| Stockholders Equity | 596.09B | 562.84B | 554.67B | 464.60B | 373.88B | 291.84B |
Cash Flow | ||||||
| Free Cash Flow | -20.73B | -43.45B | 14.81B | 20.84B | -7.10B | 45.07B |
| Operating Cash Flow | 37.75B | 9.55B | 36.46B | 64.99B | 47.01B | 74.11B |
| Investing Cash Flow | -67.18B | -59.13B | -65.33B | -47.20B | -49.03B | -21.78B |
| Financing Cash Flow | 9.45B | 26.89B | 35.39B | -2.79B | 8.77B | -24.06B |
Dentium Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:145720, the sentiment is Positive. The current price of 40350.00 is above the 20-day moving average (MA) of 39300.00, above the 50-day MA of 38127.00, and below the 200-day MA of 44741.79, indicating a neutral trend. The MACD of 451.54 indicates Negative momentum. The RSI at 56.85 is Neutral, neither overbought nor oversold. The STOCH value of 70.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KR:145720.
Dentium Co., Ltd. Peers Comparison
Overall Rating
- KR:14572063.5Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| KR:145720 | 64Neutral | KRW 347.97B | 11.30 | ― | 1.49% | -6.55% | -58.05% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| KR:145720 | Dentium Co., Ltd. | 40350.00 | -16485.26 | -29.01% | |
| KR:042520 | Hans Biomed Corp | 17030.00 | -7120.00 | -29.48% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 28, 2026